Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease

Overview of attention for article published in Clinical Ophthalmology, June 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,703 followers.

RT @hhperez2011: Lifitegrast, un nuevo tratamiento para el ojo seco. @CARBOMERO940. https://t.co/DSgNJhFtmi

RT @hhperez2011: Lifitegrast, un nuevo tratamiento para el ojo seco. @CARBOMERO940. https://t.co/DSgNJhFtmi

Development of #lifitegrast: a novel T-cell inhibitor for the treatment of #dry eye disease. - #PubMed - NCBI https://t.co/DN97usjniS